Cargando…
Glycine protects against doxorubicin-induced heart toxicity in mice
Doxorubicin (DOXO) is a well-known cancer chemotherapeutic. However, its toxic effect on the heart limits its clinical application. This study aimed to assess the effectiveness of glycine administration to counteract the DOXO-induction of cardiomyopathy in mice. Fifty male albino mice were divided i...
Autores principales: | Shosha, Mayada I., El-Ablack, Fawzia Z., Saad, Entsar A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247571/ https://www.ncbi.nlm.nih.gov/pubmed/36967438 http://dx.doi.org/10.1007/s00726-023-03261-w |
Ejemplares similares
-
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
por: Basal, Omnia A., et al.
Publicado: (2023) -
In Vivo Protection against Strychnine Toxicity in Mice by the Glycine Receptor Agonist Ivermectin
por: Maher, Ahmed, et al.
Publicado: (2014) -
Biochemical studies on the protective effect of honey against doxorubicin-induced toxicity in BALB/C mice
por: Alhumaydhi, Fahad A.
Publicado: (2020) -
EPAC1 inhibition protects the heart from doxorubicin-induced toxicity
por: Mazevet, Marianne, et al.
Publicado: (2023) -
Asiatic Acid Protects against Doxorubicin-Induced Cardiotoxicity in Mice
por: Hu, Xiaoping, et al.
Publicado: (2020)